The University of Chicago Header Logo

Connection

Sonali Smith to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Sonali Smith has written about Treatment Outcome.
Sonali Smith
Connection Strength
0.160
Treatment Outcome
  1. New drugs for the treatment of non-Hodgkin lymphomas. Chin Clin Oncol. 2015 Mar; 4(1):14.
    View in: PubMed
    Score: 0.051
  2. The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance). Leuk Lymphoma. 2013 Jul; 54(7):1405-10.
    View in: PubMed
    Score: 0.044
  3. Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium. J Clin Oncol. 2010 Nov 01; 28(31):4740-6.
    View in: PubMed
    Score: 0.037
  4. Something old, something new.... Leuk Lymphoma. 2006 Apr; 47(4):576-7.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.